Plasma prostasin: a novel risk marker for incidence of diabetes and cancer mortality.
Xue BaoBiao XuIram Faqir MuhammadPeter M NilssonJan NilssonGunnar EngströmPublished in: Diabetologia (2022)
Plasma prostasin levels are positively associated with diabetes risk and with cancer mortality risk, especially in individuals with high blood glucose levels, which may shed new light on the relationship between diabetes and cancer.